William Pao

Dr. William Pao, CEO and co-founder of Revelio Therapeutics, shares his compelling journey from losing his father to colon cancer at 13 to spearheading breakthroughs in lung cancer research. He discusses the discovery of EGFR mutations and the fierce competition in publishing this pivotal finding. Dr. Pao highlights the serendipitous origins of Tylenol and delves into drug development challenges in the biotech world. He offers valuable insights on resilience for aspiring entrepreneurs and the future of medical innovation.